Skip to content
  • Sunday, 26 July 2026
  • 1:45 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Duke-NUS Researchers Identify DEAF1 Protein as Key Regulator in Muscle Regeneration and Treatment for Sarcopenia and Cachexia
Stem Cell & Regenerative Medicine

Duke-NUS Researchers Identify DEAF1 Protein as Key Regulator in Muscle Regeneration and Treatment for Sarcopenia and Cachexia

Dwi Wanna May 30, 2026 0

In an era defined by a rapidly aging global population, the medical community is facing an unprecedented rise in age-related…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Researchers Discover Molecular Switch Regulating Muscle Regeneration and Sarcopenia

Dwi Wanna May 8, 2026 0

The global demographic shift toward an ageing population has brought age-related health conditions to the forefront of medical research, with…

Read More
Stem Cell & Regenerative Medicine

Duke-NUS Medical School Scientists Discover DEAF1 Protein Mechanism as Key to Reversing Muscle Loss in Sarcopenia and Cancer Cachexia

Dwi Wanna Mar 24, 2026 0

As the global population undergoes a profound demographic shift toward an older age profile, the prevalence of age-related physical decline…

Read More
Yale Research Team Deciphers Molecular Mechanism Blocking Fertilization Paving the Way for New Contraceptive and Infertility TreatmentsMIT Neuroscientists Discover Millions of Silent Synapses in the Adult Brain Unlocking New Potential for Lifelong LearningBacteria Navigate Surfaces Through Unexpected Metabolic and Molecular MechanismsAs cell therapies scale and CDMOs cut staff, process know-how is often getting lost in tech transfer
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ